[HTML] nih.gov

[HTML][HTML] Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease

OO Badmus, AA da Silva, X Li, LC Taylor… - FASEB …, 2024 - ncbi.nlm.nih.gov
The leading cause of death among patients with metabolic dysfunction‐associated steatotic
liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD …
相关文章

Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction-associated steatotic liver disease

OO Badmus, AA da Silva, X Li… - FASEB …, 2024 - pubmed.ncbi.nlm.nih.gov
The leading cause of death among patients with metabolic dysfunction-associated steatotic
liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD …

Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease

OO Badmus, AA da Silva, X Li, LC Taylor… - FASEB …, 2024 - Wiley Online Library
The leading cause of death among patients with metabolic dysfunction‐associated steatotic
liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD …

Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction-associated steatotic liver disease.

OO Badmus, AA da Silva, X Li, LC Taylor… - FASEB …, 2024 - europepmc.org
The leading cause of death among patients with metabolic dysfunction‐associated steatotic
liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD …